Kanayama H, Yokota K, Kurokawa Y, Kagawa S, Yokozeki H, Inai T, Ogawa I, Akazawa S, Hashimoto H, Mizuta K
Dept. of Urology, School of Medicine, University of Tokushima.
Gan To Kagaku Ryoho. 1999 Apr;26(5):651-5.
Intravesical instillation of tetrahydropyranyl-adriamycin (THP) was performed on 51 patients with superficial bladder cancer after transurethral resection (TUR) for prophylaxis of recurrence. The instillation was carried out with 20 mg of THP dissolved in 40 ml of distilled normal saline. Instillation was performed once 24 hours postoperatively, 9 times every 2 weeks, and 8 times every 4 weeks. These drugs were instilled for 30 to 60 minutes. The recurrence-free survival at 1, 2 and 3 years was 74.5%, 64.6% and 58.0%, respectively. Side effects of THP instillation were observed in only 4 cases (7.8%) as slight urinary frequency or micturition pain. Cases involving 5 or more tumors, or tumors measuring 3 cm or larger, more frequently demonstrated recurrence. The cases that did not respond to preoperative intravesical instillation of THP demonstrated a high frequency of recurrence. Intravesical instillation of THP as a prophylaxis against recurrence of superficial bladder cancer was effective in selected patients.
对51例浅表性膀胱癌患者在经尿道切除(TUR)术后进行膀胱内灌注四氢吡喃阿霉素(THP)以预防复发。将20毫克THP溶解于40毫升蒸馏生理盐水中进行灌注。术后24小时进行一次灌注,每2周9次,每4周8次。这些药物灌注30至60分钟。1年、2年和3年的无复发生存率分别为74.5%、64.6%和58.0%。仅4例(7.8%)观察到THP灌注的副作用为轻微尿频或排尿疼痛。涉及5个或更多肿瘤或肿瘤大小为3厘米或更大的病例更频繁地出现复发。对术前膀胱内灌注THP无反应的病例复发频率较高。膀胱内灌注THP作为预防浅表性膀胱癌复发在部分患者中是有效的。